Determinants of cardiorenal damage progression in normotensive and never-treated hypertensive subjects

Kidney International

Volumn 67, Issue 5, 2005, Pages 1974-1979

  Fesler, Pierre ^a   Ribstein, Jean ^a   Du Cailar, Guilhem ^a   Mimran, Albert ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

Blood pressure; Cardiac geometry; Longitudinal study; Renal function; Target organ damage

Indexed keywords

ALBUMIN; ALDOSTERONE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 17744399729     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00297.x     Document Type: Article

References (22)

1. LINDEMAN RD, TOBIN JD, SHOCK NW: Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26:861-868, 1984
2. LJUNGMAN S, WIKSTRAND J, HARTFORD M, et al: Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension. Am J Hypertens 6:554-563, 1993
3. HOLLENBERG NK, ADAMS DF, SOLOMON HS, et al: Senescence and the renal vasculature in normal man. Circ Res 34:309-316, 1974
4. FLISER D, FRANEK E, JOEST M, et al: Renal function in the elderly: Impact of hypertension and cardiac function. Kidney Int 51:1196-1204, 1997
5. FESLER P, DU Cailar G, RIBSTEIN J, MIMRAN A: Left ventricular remodeling and renal function in never-treated essential hypertension. J Am Soc Nephrol 14:881-887, 2003
6. SIEWERT-DELLE A, LJUNGMAN S, HARTFORD M, WIKSTRAND J: Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension. Am J Hypertens 9:841-849, 1996
7. RIBSTEIN J, DU CAILAR G, MIMRAN A: Glucose tolerance and age-associated decline in renal function of hypertensive patients. J Hypertens 19:2257-2264, 2001
8. NASCHITZ JE, GAITINI L, LOEWENSTEIN L, et al: In-field validation of automatic blood pressure measuring devices. J Hum Hypertens 14:37-42, 2000
9. GUIDELINES SUBCOMMITTEE: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17:151-183, 1999
10. MIMRAN A, DESCHODT G: The role of the renin-angiotensin system in the hormonal and renal responses to tilt in normal man. Ren Physiol 6:36-42, 1983
11. DU CAILAR G, RIBSTEIN J, DAURES JP, MIMRAN A: Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol 263:177-181, 1992
12. SCHMIEDER RE, BEIL AH, WEIHPRECHT H, MESSERLI FH: How should renal hemodynamic data be indexed in obesity? J Am Soc Nephrol 5:1709-1713, 1995
13. VASAN RS, LARSON MG, LEIP EP, et al: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 358:1682-1686, 2001
14. GOLDSTEIN IB, SHAPIRO D, GUTHRIE D: A 5-year follow-up of ambulatory blood pressure in healthy older adults. Am J Hypertens 16:640-645, 2003
15. CARAMORI ML, GROSS JL, PECIS M, DE AZEVEDO MJ: Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: An 8-year follow-up study. Diabetes Care 22:1512-1516, 1999
16. KLAG MJ, WHELTON PK, RANDALL BL, et al: Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18, 1996
17. MOGENSEN CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31:673-689, 1987
18. BIGAZZI R, BIANCHI S, BALDARI D, CAMPESE VM: Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16:1325-1333, 1998
19. REDON J, ROVIRA E, MIRALLES A, et al: Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension. Hypertension 39:794-798, 2002
20. MANN JF, GERSTEIN HC, YI QL, et al: Development of renal disease in people at high cardiovascular risk: Results of the HOPE randomized study. J Am Soc Nephrol 14:641-647, 2003
21. FESLER P, DU CAILAR G, RIBSTEIN J, MIMRAN A: Heterogeneity of cardiorenal characteristics in normotensive subjects. Hypertension 43:219-223, 2004
22. SATO A, SUZUKI Y, SARUTA T: Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension. Hypertens Res 22:17-22, 1999